Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000534232 | SCV000512986 | likely benign | not provided | 2021-02-03 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge |
Color Diagnostics, |
RCV001178109 | SCV001342465 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-11-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001429070 | SCV001631780 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2022-10-23 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000438079 | SCV001737858 | likely benign | not specified | 2021-05-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001178109 | SCV002749400 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-07-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV003995956 | SCV004823146 | likely benign | Marfan syndrome | 2024-01-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000534232 | SCV005050929 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | FBN1: BP4, BP7 |